Investors
Financial results and events
2021
- Annual General Meeting 2021 (25 March 2021)
- Dividend payment for B shares (30 March 2021)
- Silent period (1 April - 5 May 2021)
- Dividend payment for ADRs (9 April 2021)
- Q1 2021 financial results release (5 May 2021)
- Silent period (1 July - 5 August 2021)
- Q2 2021 financial results release (5 August 2021)
- Interim dividend payment for B shares (18 August 2021)
- Interim dividend payment for ADRs (25 August 2021)
- Silent period (1 October - 3 November 2021)
- Q3 2021 financial results release (3 November 2021)
2020
- Annual report 2020 (UK)
-
Company
announcement
- Novo Nordisk CEO reflects on the full year results (video)
- Investor presentation
-
Conference call webcast (03 February 2021,
13:00 CET)
- Conference call audio link (03 February 2021, 13:00 CET)
- London webcast (05 February 2021, 12:00 CET)
- London earnings presentation audio link (05 February 2021, 12:00 CET)
- Financial workbook
- Company Announcement
- Investor presentation
- Conference call webcast (30 Oct 2020, 13:00 CET)
- Conference call audio link (30 Oct 2020, 13:00 CET)
- London webcast (2 Nov 2020, 13:00 CET)
- London earnings presentation audio link (2 Nov 2020, 13:00 CET)
- Financial workbook
- Company announcement
- Investor presentation
- Conference call webcast (6 Aug 2020, 13:00 CET)
- Conference call audio link (6 Aug 2020, 13:00 CET)
- London webcast (7 Aug 2020, 13:00 CET)
- London earnings presentation audio link (7 Aug 2020, 13:00 CET)
- Financial workbook
- Company announcement
- Investor presentation
- Conference call
webcast (6 May 2020, 13:00 CET)
- Conference call audio link (6 May 2020, 13:00 CET)
- London webcast (7 May
2020, 13:00 CET)
- London earnings presentation audio link (7 May 2020, 13:00 CET)
- Financial workbook
16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
30 November: ESG conference call
- Presentation (webcast)
-
ESG presentation (pdf)
- Introduction
- Circular for Zero followed by Q&A
- Defeat Diabetes and Sustainable Workplace followed by Q&A
- Governance structure followed by
Q&A
9 October: Novo Nordisk raises sales and operating profit outlook
for 2020
19 June: R&D investor presentation
26 March: Annual General Meeting
2019
- Conference call webcast (5 February, 13:00 CET)
- London webcast (6 February, 14:15 CET)
- Conference call webcast (1 November, 13:00 CEST)
- London webcast (4 November, 14:15 CEST)
2018
2017
2016
Corporate responsibility
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Contact investor relations
Shareholders and financial analysts should address inquiries concerning Novo Nordisk and its business operations to the Investor Relations Officers. The first day after the end of each quarter until the day of the release of the quarterly report are quiet periods with no broad business discussions with investors and financial analysts.
Investors
Share price
{{priceData.date}} {{priceData.time}}
